PNPLA3 and steatosis: While the I148M variant determines a loss of enzymatic activity [74] and steatosis development seems to depend upon the accumulation of the mutant 148M PNPLA3 on the surface of lipid droplets [75], the deletion of the protein has no pathological phenotype.